ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 120 filers reported holding ANTARES PHARMA INC in Q4 2018. The put-call ratio across all filers is 2.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $116,000 | -87.9% | 49,100 | -76.0% | 0.00% | -88.9% |
| Q4 2019 | $962,000 | +187.2% | 204,700 | +85.4% | 0.01% | +80.0% |
| Q1 2019 | $335,000 | -60.4% | 110,408 | -64.5% | 0.01% | -66.7% |
| Q4 2018 | $847,000 | +810.8% | 311,400 | +974.9% | 0.02% | +650.0% |
| Q2 2017 | $93,000 | -76.3% | 28,970 | -79.1% | 0.00% | -75.0% |
| Q1 2017 | $393,000 | +495.5% | 138,512 | +83.9% | 0.01% | +700.0% |
| Q1 2016 | $66,000 | – | 75,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |